Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome
RMAT designation follows FDA’s review of available safety and efficacy data from the first three patients dosed with the low ...
ALS News Today7d
Qalsody slows ALS disease progression in real-world settings
Qalsody also stabilized patients' quality of life and lowered nerve damage-related biomarkers, consistent with data ...
11 Analysts Assess Taysha Gene Therapies: What You Need To Know
Throughout the last three months, 11 analysts have evaluated Taysha Gene Therapies (NASDAQ:TSHA), offering a diverse set of opinions from bullish to bearish. In the table below, you'll find a summary ...
These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler
Audentes Fortuna iuvat,’ wrote Virgil in his classic epic, the Aeneid. The saying, translated as ‘Fortune favors the bold,’ ...